Goldman Sachs Starts Qiagen NV (QGEN) at Sell, Sees 12% Downside

February 23, 2011 6:53 AM EST Send to a Friend
Goldman Sachs initiates coverage on Qiagen NV (NASDAQ: QGEN) with a Sell rating and $18 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login